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Abstract 
Purpose​: To determine the predictive value of postoperative bleb morphological features and 
intraocular pressure (IOP) on the success rate of trabeculectomy. 
Methods​: In this prospective interventional case series, we analyzed for one year 80 consecutive open 
angle glaucoma patients who underwent mitomycin-augmented trabeculectomy. Bleb morphology was 
scored using the Indiana bleb appearance grading scale (IBAGS). Success was defined as IOP ≤15 mmHg 
with or without medications at 12 months. We tested for IOP and bleb morphological differences 
between groups, applied a multivariable regression analysis and determined the area under the 
receiver operating characteristic curve (AUC).  
Results​: Age and gender were equally distributed (62.3±13.1 years, P=0.911). IOP of patients with a 
successful outcome did not differ from unsuccessful ones on day 1, 7 and 30 (all P≥0.2)). The AUC of 
IOP at day 1, day 7 and 30 for predicting a successful outcome was 0.355, 0.452, and 0.80, respectively. 
The AUC for bleb morphology parameters, bleb height, extension, and vascularization, on day 14 were 
0.368, ​0.408, and 0.549, ​respectively. Values for day 30 were 0.428, 0.563, and 0.654. IOP change from 
day 1 to day 30 was a good predictor of failure (AUC=0.838, 95% CI: 0.704 to 0.971) with a change of 
more than 3 mmHg predicting failure with a sensitivity of 82.5% (95% CI: 68 to 91%) and a specificity of 
87.5% (95% CI: 53 to 98%). 
Conclusion: ​The​ ​postoperative IOP on day 30 had a fair to good accuracy while the bleb features failed 
to predict a successful outcome. An IOP increase by as little as more than 3 mmHg during the first 30 
days was a good predictor of failure. 
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Introduction 
The number of trabeculectomies has sharply declined in the last decades in most developed countries 
[1,2]​ for several reasons: more surgeons are now trained in microincisional glaucoma surgeries ​[3,4] 
which can be performed sooner due to a superior risk profile ​[5]​; laser trabeculoplasty devices have 
become more affordable and are used as the first line of treatment ​[6,7]​; finally prostaglandin 
analogues are now available as generic, less expensive eye medications further reducing the number of 
trabeculectomies ​[6]​. However, in economies categorized as developing by the International Monetary 
Fund ​[8]​ and countries not in the upper quartile of the Human Development Index ​[9]​, 
trabeculectomies remain the leading surgeries for moderate and severe glaucomas ​[10,11]​. Although 
trabeculectomies have a considerable complication rate ​[12]​, they remain a common primary 
procedure for advanced glaucoma because they lower intraocular pressure (IOP) effectively and are 
not as expensive as epibulbar glaucoma drainage devices ​[13]​ which involve a comparable surgical 
effort and risk profile.  
Careful patient selection and postoperative management are key to making trabeculectomies 
successful. Recognized risk factors are, among others, younger age, a higher baseline IOP, and 
inflammation ​[14,15]​. While careful preoperative planning, intraoperative use of antifibrotics, and the 
surgical technique impact the outcome, the postoperative period plays an equally important role 
[16,17]​ including adjustment of the frequency of postoperative visits, adjustment of steroid frequency, 
release or lasering of scleral flap sutures, bleb massage, and bleb needling. Yet, even with the most 
personalized postoperative care, the individual wound healing and tissue remodeling make predicting 
a successful outcome difficult. Several recent studies have tried to capture the specific wound healing 
by correlating the early postoperative IOP or the bleb morphology with long-term outcomes and found 
that a low early postoperative IOP produces favorable long-term outcomes ​[18–21]​. In contrast, bleb 
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grading systems are more complex, less objective but hold promise to describe data that is otherwise 
difficult to quantify; they have not been widely adopted ​[22,23]​.  
The purpose of our study was to validate in our patient population the accuracy of the early 
postoperative IOP and bleb morphology (Indiana Bleb Appearance Grading Scale (IBAGS)) as a test to 
predict a failure of trabeculectomy at 12 months. In contrast to prior studies, we also examined the 
role of an IOP increase during the first 30 postoperative days in predicting such failure.  
 
Methods  
Study design 
Eighty eyes of 80 consecutive patients diagnosed with primary open angle glaucoma were included in 
this prospective observational study. In patients who had trabeculectomies in both eyes, the eye was 
chosen using a random number generator ​[24]​. The study was performed at the glaucoma clinic of the 
Labbafinejad Medical Center from September 2013 to March 2015. The study was approved by the 
ethics committee and the institutional review board at the Ophthalmic Research Center (protocol 
number: IR.SBMU.ORC.REC.1393.2) and followed the tenets of the Declaration of Helsinki. Informed 
written consent was obtained from each participant. Inclusion criteria were equal or above 30 years of 
age and progressive primary open angle glaucoma (glaucomatous optic neuropathy, retinal nerve fiber 
layer loss and corresponding visual field defect on standard automated perimetry) that could not be 
controlled medically. Exclusion criteria consisted of prior ocular surgery, manipulation of the 
conjunctiva, a necessity for combining trabeculectomy with cataract extraction, ocular or systemic 
comorbidities that could affect the procedure and study outcomes such as immunodeficiency, 
connective tissue disease, and uncontrolled diabetes. At baseline, all patients underwent a 
comprehensive ophthalmic examination including determination of best-corrected visual acuity 
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(BCVA), slit lamp examination, Goldmann applanation tonometry, gonioscopy, and fundus 
examination. 
 
Surgical technique and postoperative management 
All the surgeries were performed by two surgeons in equal numbers (HE and MP) as described in the 
following. After administration of intravenous sedation, a peribulbar block was placed using 2 milliliters 
(ml) of 2% lidocaine (Lignidic 2%, Caspian Tamin Pharmaceutical Co., Rasht, Iran). Following lid 
speculum insertion and cul de sacs irrigation with povidone-iodine and normal saline solution, a 7-0 silk 
traction suture was placed through the superior peripheral cornea. A superior peritomy was fashioned 
over 1-½ clock hours, and Tenon’s capsule was dissected with Westcott scissors. A 3.0 × 4.0 mm 
trapezoidal half-thickness scleral flap was fashioned using a crescent knife followed by lamellar 
dissection of the flap 1mm into the clear cornea. After creating the scleral flap, small pieces of 0.02% 
MMC (Mitomycin C, Kyowa, Kogyo Company, Tokyo, Japan) soaked cellulose sponges were placed 
under the Tenon and conjunctiva over the scleral flap for 3 minutes. After removing the sponges and 
vigorously irrigating the area with 50 ml of balanced salt solution (BSS), the anterior chamber was 
entered with a small keratome, and a block of clear cornea was removed with a 1 mm Kelly punch 
followed by a peripheral iridectomy using Vannas scissors. The scleral flap was then secured using two 
10-0 nylon releasable sutures. The anterior chamber was formed by injection of BSS a paracentesis, 
and the filtration was titrated by adjusting the tension of the scleral flap sutures. The conjunctiva was 
closed using 10-0 nylon wing sutures. Cefazolin 50 mg (Cefazolin 500, Exir Pharmaceutical Co, Tehran, 
Iran) and betamethasone 2 mg (Betazone, Caspian Tamin Pharmaceutical CO., Rasht, Iran) were 
injected subconjunctivally into the inferior fornix, and the eye was patched.  
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The postoperative regimen consisted of chloramphenicol 0.5% eye drops (Sina Darou Lab. Co., 
Tehran, Iran) 4 times a day for 1 week and betamethasone 0.1% eye drops (Sina Darou Lab. Co., 
Tehran, Iran) 6 times a day, which was tapered over 8 to 12 weeks depending on the degree of 
inflammation. The releasable sutures were removed as needed after 72 hours depending on bleb 
appearance to achieve IOPs near 10 mmHg. Needling was done during the postoperative period for 
impending failure from a contracting bleb. Thirty minutes after injecting 0.1 ml of 0.02% mitomycin C 
into the bleb-adjacent subtenon space a 27 gauge needle was used to reform the bleb and dissect 
adhesions at the slit lamp. 
We saw our patients on a weekly basis for one month and then monthly for 12 months. At each 
postoperative visit, BCVA, IOP, bleb morphology, glaucoma medications, and complications were 
noted. A slit lamp photograph of the blebs was obtained at each visit (​Haag-Streit BX 900 slit 
lamp, Haag-Streit Diagnostics​, ​Köniz​, Switzerland). Two glaucoma surgeons, masked to surgeon and 
patient, graded the bleb images on the Indiana Bleb Appearance Grading Scale (IBAGS). The IBAGS 
variables included the bleb height (H0-H3), extent (E0-E3), vascularity (V0-V4), and leakage (S0-S2)​ ​[23]​. 
A trabeculectomy was considered successful if IOP was equal or less than 15 mmHg with or without 
antiglaucoma medications ​[18]​. Failure was defined as IOP>​15 mmHg ​with glaucoma medications ​or 
less than 5 mm Hg ​at the final visit.  
Statistics 
Data was described as mean±standard deviation (SD), median, range, 95% confidence interval (95% CI) 
and frequency (percentage).  To evaluate for difference between the two groups we used the ​t​-test, 
Mann-Whitney, Chi-square and Fisher exact test.​ A change in visual acuity before and after surgery was 
evaluated by the Wilcoxon signed-rank test. The predictive power of bleb variables was measured with 
the area under the receiver operator characteristic curve (AUC). In order to find the relative risk (RR, 
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Supplemental Table) of failure by bleb morphology and IOP at the 1-month visit, a Cox regression with 
defined constant time was used. Youden's J statistic was used to capture the performance of variables 
(bleb morphology, IOP) as a diagnostic test. All statistical analyses were done with the SPSS software 
package (IBM Corp. Released 2016. IBM SPSS Statistic for Windows, Version 24.0, Armonk, NY). 
 
Results 
A total of 80 patients were enrolled in this study.  This sample size and ratio of success and failure 
provided an above 90% power to detect an AUC difference of 0.5 ​[25]​. Forty-four eyes would have 
provided a power of 80% to detect an IOP change of 3 mmHg while 80 eyes allowed for a 97% power. 
The mean age of study participants was 62.3±13.1 years, and 51.3% of the patients were male 
(P=0.911). The patients’ demographic data are presented in ​Table 1​. The procedure was considered 
successful in 64 patients (80%) at 12 months follow-up.  
 
Table 1: Baseline characteristics of participants (mean±SD, median (range)). 
  Total Success P 
  No (n=16) Yes (n=64) 
age 62.3±13.1 63.2±16.3 62±12.3 0.430† 
     
male 41 (51.3%) 8 (50.0%) 33 (51.6%) 0.911* 
female 39 (48.8%) 8 (50.0%) 31 (48.4%)  
     
BCVA 0.47±0.47 0.37±0.37 0.49±0.49 0.334‡ 
 0.3 (0 - 2.8) 0.24 (0 - 1.1) 0.3 (0 - 2.8)  
     
IOP 21.8±5.0 20.4±3.3 22.1±5.3 0.171‡ 
 21 (11 - 32) 20 (16 - 28) 22.5 (11 - 32)  
     
medications 1.2±1.6 1.4±1.9 1.2±1.6 0.785‡ 
  0 (0 - 4) 0 (0 - 4) 0 (0 - 4)   
     
HVF MD 16.9 ± 5.8 -16.2 ± 5 -17 ± 6 0.645‡ 
 -16.9 (-28.2 - -4.9) -16.3 (-26.4 - -10.3) -17.4 (-28.2 - -4.9)  
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VCD-ratio 0.91 ± 0.93 0.84 ± 0.12 0.92 ± 1 0.666‡ 
 0.8 (0.05 - 9) 0.85 (0.7 - 1) 0.8 (0.05 - 9)  
BCVA: Best Corrected Visual Acuity. Medications: topical glaucoma medications. IOP: Intraocular 
Pressure. HVF MD: Humphrey visual field mean deviation. VCD: vertical cup disc ratio† Based on t-test. 
‡ Based on Mann-Whitney test. * Based on Chi-Square test. 
 
 
There were no significant differences between the success and failure groups in terms of age, the 
number of preoperative antiglaucoma medications, preoperative IOP, visual field mean deviation or 
vertical cup-disc ratios​ (Table 1)​.  The postoperative IOP was not different between these groups at any 
time ​(Table 2)​.  
 
Table 2: Intraocular pressure at each pre- and postoperative visit. 
  
 Time 
No success Success 
P‡ AUC 
95% CI 
Mean±SD Median 
(range) 
Mean±SD Median 
(range) 
Lower 
Upper 
Baseline 21.2±3.4 20 (17 - 28) 21.9±5.2 21 (11 - 32) 0.654 0.473 0.297 0.65 
Day 1 6±2.4 6.5 (3 - 9) 7.4±2.5 8 (2 - 13) 0.193 0.355 0.147 0.562 
Week 2 7.1±2.1 7 (3 - 10) 7.8±2.5 8 (4 - 18) 0.639 0.452 0.239 0.664 
Month 1 9.3±4.6 10 (2 - 16) 8.4±2.4 9 (3 - 19) 0.238 0.8 0.581 1 
Month 3 12.6±6.8 14 (2 - 21) 9.5±2.5 10 (5 - 17) 0.143 0.85 0.635 1 
Month 6 14.1±7.7 17 (4 - 23) 9.9±2 10 (5 - 15) 0.133 0.875 0.646 1 
Month 12 13.7±7.3 17 (4 - 23) 10.1±1.7 10 (6 - 15) 0.143 0.875 0.646 1 
‡ Based on Mann-Whitney test.  
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 The best corrected visual acuity did not change significantly (0.47±0.47 logMAR at baseline, 0.48±0.48 
postoperatively, P=0.492). Mean IOP decreased significantly from 21.8±5 mmHg at baseline to 
10.6±3.8 mmHg at 12 months (p<0.001), and 25 patients needed glaucoma medications to have their 
IOP within the target range. There were no intraoperative complications. The most common 
postoperative complication was a shallow anterior chamber, followed by bleb leakage and hyphema as 
summarized in ​Table 3​.  
 
Table 3: List of postoperative complications. 
  
Total 
Success 
P 
  No Yes 
Bleb leakage 6 (7.5%) 3 (18.8%) 3 (4.7%) 0.091** 
Bleb resuturing 1 (1.3%) 0 (0.0%) 1 (1.6%) >0.99** 
Hyphema 6 (7.5%) 2 (12.5%) 4 (6.3%) 0.594** 
Shallow anterior 
chamber 
8 (10.0%) 
3 (18.8%) 5 (7.8%) 
0.194** 
Bleb needling 10 (12.5%) 8 (50.0%) 2 (3.1%) <0.001** 
** Based on Fisher exact test.‡ Based on Mann-Whitney test. 
 
The difference between success and failure groups in a leak, repeat suture, hyphema and shallow 
anterior chamber were insignificant ( P=0.09, 0.99, 0.59, and 0.18, respectively). Bleb needling was 
more frequently performed in the group that failed (P<0.001). One eye experienced hypotony 
maculopathy. Patients with a ﬁnal IOP of ≤15 mmHg had a mean day 1 IOP of 7.4±2.5 mmHg compared 
with 6±2.4 mmHg in those with an IOP above 15 mmHg at ﬁnal follow-up (P=0.193). Respective values 
for day 7 were 7.8±2.5 and 7.1±2.1 mmHg (P=0.639), and for day 30 values were 8.4±2.4 and 9.3±4.6 
mmHg (P=0.238). The AUC for IOP at day 1, day 7 and 30 as a predictor of success was 0.355, 0.452, 
and 0.80 respectively. The bleb morphology parameters according to the IBAGS are detailed in ​Table 4​.  
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Table 4: Bleb morphologic characteristics at each postoperative visit. 
Parameter Time 
No success   Success   
P‡ AUC 
95% CI 
Mean±SD Median (range) Mean±SD 
Median 
(range) 
Lower Upper 
Bleb H Week 2 2.45±0.69 3 (1 to 3)  2.17±0.54 2 (1 to 3)  0.098 0.368 0.172 0.564 
 Month 1 2.27±0.65 2 (1 to 3)  2.12±0.53 2 (1 to 3)  0.35 0.428 0.233 0.624 
 Month 3 1.64±0.67 2 (1 to 3)  1.96±0.4 2 (1 to 3)  0.024 0.652 0.444 0.859 
 Month 6 1.36±0.5 1 (1 to 2)  1.78±0.54 2 (1 to 3)  0.017 0.691 0.523 0.859 
 Month 12 1.36±0.5 1 (1 to 2)  1.74±0.56 2 (1 to 3)  0.038 0.669 0.5 0.838 
            
Bleb E Week 2 2.55±0.52 3 (2 to 3)  2.36±0.48 2 (2 to 3)  0.25 0.408 0.224 0.592 
 Month 1 2.18±0.4 2 (2 to 3)  2.3±0.49 2 (1 to 3)  0.41 0.563 0.391 0.734 
 Month 3 1.73±0.65 2 (1 to 3)  2.12±0.4 2 (1 to 3)  0.012 0.669 0.47 0.869 
 Month 6 1.55±0.52 2 (1 to 2)  2.09±0.37 2 (1 to 3)  <0.001 0.744 0.568 0.92 
 Month 12 1.82±0.75 2 (0 to 2)  1.95±0.53 1 (0 to 1)  0.002 0.749 0.57 0.928 
            
Bleb V Week 2 2.18±0.6 2 (1 to 3)  2.3±0.49 2 (1 to 3)  0.53 0.549 0.357 0.74 
 Month 1 1.82±0.6 2 (1 to 3)  2.19±0.52 2 (1 to 3)  0.045 0.654 0.474 0.834 
 Month 3 1.64±0.67 2 (0 to 2)  1.86±0.49 2 (1 to 3)  0.368 0.565 0.38 0.751 
 Month 6 1.55±0.69 2 (0 to 2)  1.54±0.53 2 (0 to 2)  0.76 0.475 0.282 0.668 
 Month 12 1.36±0.67 1 (0 to 2)  1.46±0.53 1 (0 to 2)  0.702 0.532 0.338 0.725 
H: height. E: extension. V: vascularization. ‡ Based on Mann-Whitney test. 
 
The AUC for bleb morphology parameters of bleb height, extension, and vascularization on day 14 
were 0.368, 0.408 and 0.549, respectively. The AUC values for day 30 were 0.428, 0.563, and 0.654. 
Based on the AUCs, there was no single bleb variable at month 1 to predict success at month 12. 
Surprisingly, the AUC of the IOP change from day 1 to day 30 was a good predictor of success 
(AUC=0.838, 95% CI: 0.704 to 0.971, ​Supplementary Table​). Based on Youden’s J index, the change in 
IOP less than or equal to 3 mmHg could predict the success in month 12 with the sensitivity of 82.5% 
(95% CI: 68 to 91%) and specificity of 87.5% (95% CI: 53 to 98%). 
 
Discussion 
Trabeculectomy remains a common surgery to lower IOP in glaucoma patients and has a long history. 
In 1958, Grant first described a guarded filtering procedure in enucleated eyes with subsequent facility 
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measurements which he termed trabeculectomy ​[26]​. Sugar followed by performing the first 
trabeculectomy in patients in 1961 ​[27]​ while Cairns popularized the term and technique by providing 
detailed drawings and figures ​[28]​. The procedure was eventually made more effective by adding 
mitomycin-C as an antifibrotic ​[29]​ and somewhat titratable by using sutures that can be lasered or 
manually released ​[30,31]​. The variable success rate of this procedure can be improved by careful 
patient selection, surgical technique ​[32]​, and postoperative management ​[15]​. Identifying patients at 
risk is critical because a timely intervention can improve the outcomes of trabeculectomy ​[16]​; 
preoperative factors such as high baseline IOP, number of glaucoma medications, young age, aphakia 
or pseudophakia and prior surgery with conjunctival scarring are known risk factors for failure ​[32]​. The 
success and failure groups in our study has very similar baseline IOP, medications, visual field loss and 
optic nerve damage indicating that any risk factors related to those were relatively equal in both. 
Several recent studies found that a low early postoperative IOP produces favorable long-term 
outcomes ​[18–21,33]​ but also causes more frequent and more severe complications that include a 
shallow anterior chamber, choroidal effusion, hypotony maculopathy, and vision loss ​[34]​. In contrast 
to these studies, we found only a weak relationship between IOP at day 1, 7, and 30 and long term 
success, similar to Polikoff et al. ​[35]​ ​who also reported that early post-trabeculectomy IOP is a poor 
predictor of success at one year follow-up. The accuracy of a test depends on how well it separates 
groups under study into those with and without the issue in question. Accuracy is measured by the 
area under the ROC curve and commonly classified into .90-1 = excellent, .80-.90 = good, .70-.80 = fair, 
.60-.70 = poor and .50-.60 = fail ​[25]​. In our study, the AUC for IOP was the highest on day 30 with 0.8, 
making it a fair to good predictor ​[25]​.  E​arly post-trabeculectomy IOP is affected by various factors 
that include reduced aqueous production, inflammation, the amount of TGF-beta and other growth 
factors ​[36]​, and breakdown of the blood-aqueous barrier, over filtration, and choroidal detachment. 
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In our study, the IOP appears to summarize these and other factors reasonably well to as a single 
variable that can be used as a predictor.  
Different from other studies, we also examined the change in IOP during the first 30 days and 
found that it served as a good predictor of success that performs better than the IOP itself. The cutoff 
for an at-risk IOP elevation was only 3 mmHg. Our study was not designed to discover causality. It is 
likely that this finding identifies patients at risk of failure who experienced an IOP increase despite an 
intensified treatment. It could also indicate that these were patients who received a suboptimal 
postoperative management. An increased IOP will increase the stretch of the bleb wall and incite a 
reactive fibrosis. Stretch is a well-established activator of fibroblast proliferation and fibrosis ​[37,38]​. 
This may lead to a cycle of auto-enhancing IOP increase with further increase of stretch and fibrosis 
that again elevates pressure as the bleb wall becomes thicker and the bleb contracts. In this model, IOP 
drives the morphological changes of the bleb. This order matches our AUC findings better (the AUC 
was better for IOP change than for bleb morphology) than a primary morphological change that is 
followed by increased IOP. Our observation is supportive of the practice to inject or needle with 
postoperative 5-fluorouracil or mitomycin C to reduce the fibrosis ​[39,40]​.  
Like IOP, a bleb’s morphology is a reflection of a patient’s specific wound healing that is directly 
observable but more difficult to quantify. The development of bleb grading scales was an attempt to 
approach this problem systematically ​[22,23]​. While grading systems can be useful teaching tools of 
bleb features, its inherently subjective nature and categorical data weaken the predictive power. 
Accordingly, we found only low AUC values for bleb morphology that ranged from 0.368 to 0.549 on 
day 14 and would be interpreted as a test failure. The day 30 features would be interpreted only 
slightly better, as poor. Of the variables bleb height, extension and vascularization, vascularization had 
the highest accuracy. These findings match Picht et al. ​[41]​ who concluded that an early vascularization 
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indicates a poor prognosis with higher IOP at 12 months and support the use of anti-VEGF agents 
[42,43]​.  
 
In conclusion, we found that the IOP change during the first month, rather than the IOP at each visit, 
was a good predictor of failure. The bleb morphological features did not predict failure except for bleb 
vascularity which performed poorly to fairly. These finding highlight how important it is to carefully 
observe for IOP and bleb vascularity changes and to intervene swiftly if necessary. 
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